XGEVA(TM) (Denosumab) Significantly Improved Bone Metastasis-Free Survival
- Details
- Category: Amgen
![Amgen Amgen](/images/stories/logo/amgen.gif)
Genzyme Reiterates Board's Position on sanofi-aventis Tender Offer
- Details
- Category: Genzyme
![Genzyme Genzyme](/images/stories/logo/genzyme.gif)
Bayer: 35 million Euros for the expansion of the development of biologicals
- Details
- Category: Bayer
![Bayer Bayer](/images/stories/logo/bayer.gif)
Young Children In Developing World Receive Accelerated Access to Pfizer's Prevenar 13 Vaccine
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](/images/stories/logo/pfizer_b.gif)
Middle East and North African leaders seek solutions to diabetes threat
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](/images/stories/logo/novonordisk_b.gif)
LUX-Lung 1 trial suggests benefit from afatinib* in lung cancer patients
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](/images/stories/logo/boehringeringelheim.gif)
GSK to acquire Nanjing MeiRui Pharmaceuticals in China
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
More Pharma News ...
- Three Innovative Ideas Receive $10,000 Prizes in Patients | Choices | Empowerment Competition
- Merck KGaA Donation Program Supports Schistosomiasis Control in Africa
- Encouraging Phase 2 Interim Data for Elotuzumab in Relapsed Multiple Myeloma
- Novo Nordisk presents positive clinical data on two investigational compounds within bleeding disorders
- Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib
- Public believe China and India set to become World leaders for innovation
- Rituxan/MabThera decreased the risk of needing later treatment with chemotherapy or radiotherapy by 80%